Impact of clinical trials on clinical practice: example of thrombolysis for acute myocardial infarction
- 9 October 1993
- journal article
- Published by Elsevier in The Lancet
- Vol. 342 (8876) , 891-894
- https://doi.org/10.1016/0140-6736(93)91945-i
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Do the Results of Randomized Clinical Trials of Cardiovascular Drugs Influence Medical Practice?New England Journal of Medicine, 1992
- Increased prescription of thrombolytic treatment to elderly patients with suspected acute myocardial infarction associated with audit.BMJ, 1992
- British Heart Foundation surveys (1987 and 1989) of United Kingdom treatment policies for acute myocardial infarction.Heart, 1991
- Optimizing thrombolytic therapy of acute myocardial infarction.Circulation, 1990
- Districts' use of thrombolytic agents.BMJ, 1990
- Impact of randomized clinical trials on medical practicesControlled Clinical Trials, 1989
- TRIAL OF TISSUE PLASMINOGEN ACTIVATOR FOR MORTALITY REDUCTION IN ACUTE MYOCARDIAL INFARCTIONThe Lancet, 1988
- Adoption of thrombolytic therapy in the management of acute myocardial infarctionThe American Journal of Cardiology, 1988
- INTRAVENOUS STREPTOKINASE GIVEN WITHIN 0-4 HOURS OF ONSET OF MYOCARDIAL INFARCTION REDUCED MORTALITY IN ISIS-2The Lancet, 1987
- Impact of the coronary drug project findings on clinical practiceControlled Clinical Trials, 1983